期刊文献+

中草药及有效提取物治疗丙型肝炎的现状 被引量:2

下载PDF
导出
摘要 现代医学研究证实,中草药能预防肝移植后再感染、提高聚乙二醇干扰素α抗丙型肝炎病毒(HCV )效果、阻碍 HCV非结构蛋白增加、阻止 HCV复制等多方面的功效。同时,中草药能提高患者的生活质量、改善身心状况[1],减轻药物副作用,提高患者依从性,避免因不良反应引起的减药、撤药[2]。
作者 汪萌 聂青和
出处 《肝脏》 2014年第2期140-143,共4页 Chinese Hepatology
  • 相关文献

参考文献24

  • 1Seeff LB,Curto TM,Szabo G,et ah HALT-C Trial Group Herbal product use by persons enrolled in the hepatitis C Antiviral Long- Term Treatment Against Cirrhosis ( HALT-C ) Trial. Hepatology, 2008, 47:605- 612.
  • 2Anna DP, Antonella S, Maddalena DI, et al. Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease. Evidence-Based Complementary and Alternative Medicine. Evidence-Based Complementary and Alternative Medicine, 2012: 1-19.
  • 3Kim MS, Liu DQ, Strauss JR,et al. Metabolism and disposition of gemfibrozil in wistar and multidrug resistance-associated protein 2- deficient TR rats. Xenobiotica, 2003, 33 : 1027-1042.
  • 4Morazzoni P, Magistretti MJ, Giachetti C, et al. Comparative bioavailability of silipide a new flavanolignan complex in rats. European Journal of Drug Metabolism and Pharmacokinetics, 1992,17:39-44.
  • 5Miranda SR, Lee JK, Brouwer KL, et aI. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistanceassociated protein 2 (abec2). Drug Metabolism and Disposition, 2008, 36: 2219-2226.
  • 6Scbandalik R, Gatti G, Perueca E. Pharmaeokinetics of silybin in bile flowing administration of silipide and silymarin in cholecysteetomy patients. ArzneimittebForsehung, 1992, 42: 964-968.
  • 7Schrieber SJ, Wen Z, Vourvahis M, et al. The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic fatty liver disease and correlates with plasma caspase- 3/7activity. Drug metabolism and disposition: the biological fate of chemicals, 2008, 36: 1909-1916.
  • 8Stephen J, Chihiro M, Volker L, et al. Identification of hepatoprotective flavonolignans from silymarin. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107: 5995-5999.
  • 9Kida K, Suzuki M, Matsumoto N, et al. Identification of biliary metabolites of (-)-epiga lloeatechin gallate in rats. Journal of Agricultural and Food Chemstry, 2000, 48: 4151-4155.
  • 10Jones CK, Brady AN, Davis AA, et al. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. The Journal of Neuroscience, 2008, 28: 10422-10433.

二级参考文献2

共引文献32

同被引文献11

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部